Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 7,350.00
-40.00 (-0.54%)
Last updated: Jun 4, 2026, 3:00 PM KST
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 113.44 billion as of June 3, 2026. Its market cap has decreased by -6.34% in one year.
Market Cap
113.44B
Enterprise Value
354.46B
Revenue
625.97B
Ranking
n/a
PE Ratio
8.44
Stock Price
7,350.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 113.44B, an increase of 331.42%. That is a compound annual growth rate of 4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 113.44B | -8.08% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 156.48B |
| Daihan Pharmaceutical | 154.94B |
| Samil Pharmaceutical Co.,Ltd | 154.13B |
| Ilyang Pharmaceutical Co.,Ltd | 152.90B |
| Dongwha Pharm.Co.,Ltd | 151.62B |
| SAMSUNG PHARM. Co., LTD. | 139.77B |
| Ilsung Is | 134.43B |
| Kyongbo Pharmaceutical | 132.20B |